Revisiting the isobole and related quantitative methods for assessing drug synergism
about
Pharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?Computational analyses of synergism in small molecular network motifsData-Driven Method to Estimate Nonlinear Chemical EquivalenceAnti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine AgentAn Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.Combining opioid and adrenergic mechanisms for chronic pain.Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians.Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats.Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.Cytotoxicity enhancement in MDA-MB-231 cells by the combination treatment of tetrahydropalmatine and berberine derived from Corydalis yanhusuo W. T. Wang.Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse.Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome.A military-centered approach to neuroprotection for traumatic brain injury.Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo.Analysis of drug combinations: current methodological landscape.Limitations of toxicity characterization in life cycle assessment: Can adverse outcome pathways provide a new foundation?Production of Trichophyton rubrum microspores in large quantities and its application to evaluate amorolfine/azole compound interactions in vitro.Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma.Anti-allodynic Efficacy of NMDA Antagonist Peptide and Noradrenaline Alone and in Combination in Rodent Neuropathic Pain Model.Drug Combinations: Tests and Analysis with Isoboles.Identification of combined action types in experiments with two toxicants: a response surface linear model with a cross term.A golden approach to ion channel inhibitionNovel relaxant effects of RPL554 on guinea pig tracheal smooth muscle contractility.Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats.Combination of β Adrenergic Receptor Block and Renin-Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension.Beneficial Combination of Lacosamide with Retigabine in Experimental Animals: An Isobolographic Analysis.Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition.Utilisation of the isobole methodology to study dietary peptide-drug and peptide-peptide interactive effects on dipeptidyl peptidase IV (DPP-IV) inhibition.CISNE: An accurate description of dose-effect and synergism in combination therapies.The anti-convulsants lacosamide, lamotrigine, and rufinamide reduce myotonia in isolated human and rat skeletal muscle.
P2860
Q26777927-27D0EFBF-8778-4362-8D92-97A9CCE2CF49Q28541174-FCB6E810-C75F-4BB6-85AC-1B66E8AB2315Q28546404-DB2193BD-2EB6-4241-8142-C460FA5B1E53Q28553698-94871C7B-CE98-4F3E-9E23-A190C7A582EDQ33580906-13EC98AD-742E-4E86-9E62-BDBEEC8A9FEEQ34434307-DD74345B-7E4E-4595-85E6-E274B2E72D8CQ35619877-2C78D7AC-A726-4A57-9B0E-289836450A83Q35659644-19F888D8-E0B1-4D56-81A3-1E1444316B6DQ35744338-22B84F1D-3EC8-48AC-806D-F6A1362A34B5Q36078092-D54C33C5-9413-4815-804D-BE0CEC39F07DQ36319552-C5206B8C-A9F2-4DC0-AE7B-9D700B5B8B55Q36776559-16002B8C-C7D1-449D-9BCD-7C89E8BF8F57Q36920836-87A39533-49F0-4A7A-93FA-5FFAEE26C128Q37696606-7B41E693-BCCE-472F-8FDE-D6A46DB39555Q37706827-5F3328CA-2630-4D82-8E52-74C7D4AC2448Q38546567-83BD4EA1-384F-48FB-AA99-B4A5FB147AD3Q38578965-229A585B-6A9E-4B9B-A16A-8CD87A2B86F1Q38798694-17A75204-E748-4B5E-9643-BB596480EFFEQ38810296-CF26503F-9827-4D82-BEE7-37B8F437E5DDQ38966954-1A69EE6F-01BF-4C9A-9325-09557456F567Q39310913-D0C99D71-B032-44A6-AD73-78E94B1EED7DQ39904481-7C31B40A-9AF6-4FF4-BC30-DAB4A571E926Q39984227-6105E72C-822F-43EA-8250-EBD14429393DQ42140961-F38F1049-6B48-4F36-B546-4C41A2566F46Q42419157-6D415BB0-DE30-4F90-AF0E-8C39EA415320Q44346108-0B054F0F-F147-4971-98BF-712AF24A1509Q44636397-7A93D610-B985-4440-A697-DB71F58CE05CQ48105985-57BB0411-D964-47B1-A585-558B66CE8921Q48370726-68A71DD4-04F9-4B1B-BAEF-B7C75A6250D9Q50268907-F1319357-987A-48A4-9EA9-83EEA9FC0909Q50999292-2C43BE2B-8B5E-4900-8502-F0B3DCE12401Q52643927-DE09844F-7C1C-4ED4-8532-A85304CCABF7Q54464202-F87017E1-9ECC-4A4C-B674-E4390FCE066F
P2860
Revisiting the isobole and related quantitative methods for assessing drug synergism
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Revisiting the isobole and related quantitative methods for assessing drug synergism
@ast
Revisiting the isobole and related quantitative methods for assessing drug synergism
@en
type
label
Revisiting the isobole and related quantitative methods for assessing drug synergism
@ast
Revisiting the isobole and related quantitative methods for assessing drug synergism
@en
prefLabel
Revisiting the isobole and related quantitative methods for assessing drug synergism
@ast
Revisiting the isobole and related quantitative methods for assessing drug synergism
@en
P2860
P356
P1476
Revisiting the isobole and related quantitative methods for assessing drug synergism
@en
P2860
P356
10.1124/JPET.112.193474
P407
P577
2012-04-17T00:00:00Z